The FDA has approved a novel combination therapy using Lumakras® (sotorasib) and Vectibix® (panitumumab) for adults with KRAS ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) for the treatment of adult patients with KRAS G12C ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

BCL-2 inhibitors, such as venetoclax (Venclexta) work by targeting the BCL-2 protein, which plays a key role in preventing ...

The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...

Looking back at the past year in film, action remains a reliable genre both at the box office and on streaming. Action occupies six spots on the list of the 12 highest-grossing movies of 2024.

Employing gene-technological methods such as CRISPR-Cas9 genome editing, they were able to establish the molecular mechanisms of how mitochondria counteract cellular NAD decline. "Decreased ...

When body parts or spurting blood aren’t flying into frame, you’d almost believe Woo has gone soft with how lovingly he stages the city to host the remake of his 1989 Hong Kong action classic ...

New research identifies key cellular mechanism driving Alzheimer's disease. ScienceDaily . Retrieved January 14, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241223135051.htm ...